Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Research
Caribou Biosciences Initiates Dose Expansion Portion of CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients
BERKELEY, Calif., March 29, 2023 - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company,…
Patient Education Webcasts
Spotlight On Multiple Myeloma
Research
CMML Special Initiative
Expanding research in Chronic Myelomonocytic Leukemia to better characterize its biology, develop new therapies, and optimize outcomes for patients.
Patient Education Webcasts
Clinical Trials & Blood Cancers: Searching For Cures
News
Coast to Coast Hundreds Climb over 1,000 Steps to End Blood Cancer
Coast to Coast Hundreds Climb over 1,000 Steps to End Blood Cancer
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
